Journal of Medicinal Chemistry p. 3684 - 3692 (1994)
Update date:2022-08-04
Topics: Synthesis Macrocyclic Design Conformational Analysis HIV-Protease Inhibitor
Podlogar
Farr
Friedrich
Tarnus
Huber
Cregge
Schirlin
Design modifications to the lead HIV-PR inhibitor 1 (MDL 73,669, K(i) = 5 nM) have been postulated based on a computational model of the 1/HIV-PR complex. A novel macrocyclic inhibitor 8 (MDL 104,168) wherein the P1 and P3 side chain
View MoreContact:86-21-50966856
Address:Building 5,300 Chuanzhan Road,Pudong New District,Shanghai
Hangzhou Sartort Biopharma Co., Ltd
website:http://www.sartort.com
Contact:86-571-87039693
Address:No. 57, Tech Park Road, Hangzhou, Zhejiang, China
Hangzhou Showland Technology Co., Ltd.
Contact:86-571-88920516
Address:ROOM2118,NO.553,WENSAN ROAD,HANGZHOU,CHINA
Shanghai Xinda Pharmaceuticals Co., Ltd.
Contact:86-21-33692333-8008
Address:999 Linxian Road, Jinshan Industrial Park, Shanghai, China
Shanghai Witshoot Internet Technology Co Ltd
Contact:+86-21-66390020
Address:Room 419, No.285 Luochuan Road (E)
Doi:10.1016/S0003-2670(00)87305-5
(1949)Doi:10.1007/s11243-013-9779-4
(2014)Doi:10.1016/0020-1693(94)03993-3
(1994)Doi:10.1021/jo016190t
(2002)Doi:10.1248/cpb.42.1376
(1994)Doi:10.1016/S0040-4039(00)77248-0
(1994)